Clinical Trial Update: Optimizing Subcutaneous FEntanyl titRation: RApid Achievement of Adequate Exposure When Treating Cancer-Related paIn. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating subcutaneous fentanyl titration to rapidly achieve adequate exposure for cancer-related pain. Recruitment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• FENTANYL (FENTANYL)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Cancer Pain | Phase 4 | Status: RECRUITING